Amerise Biosciences Ltd vs Likhami Consulting Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Amerise Biosciences Ltd is ₹ 0.82 as of 23 Oct 15:30 . The P/E Ratio of Amerise Biosciences Ltd changed from 17 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Likhami Consulting Ltd changed from 630 on March 2021 to 1717 on March 2026 . This represents a CAGR of 18.19% over 6 years The Market Cap of Amerise Biosciences Ltd changed from ₹ 10.9 crore on March 2021 to ₹ 3.9 crore on March 2026 . This represents a CAGR of -15.74% over 6 yearsThe Market Cap of Likhami Consulting Ltd changed from ₹ 62.69 crore on March 2021 to ₹ 393.03 crore on March 2026 . This represents a CAGR of 35.79% over 6 years The revenue of Amerise Biosciences Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0.08 crore. This represent the decline of -100% The revenue of Likhami Consulting Ltd for the Jun '26 is ₹ 0.16 crore as compare to the Mar '26 revenue of ₹ 0.34 crore. This represent the decline of -52.94% The ebitda of Amerise Biosciences Ltd for the Jun '26 is ₹ -0.08 crore as compare to the Mar '26 ebitda of ₹ 0.06 crore. This represent the decline of -233% The ebitda of Likhami Consulting Ltd for the Jun '26 is ₹ 0.02 crore as compare to the Mar '26 ebitda of ₹ 0.23 crore. This represent the decline of -91.3% The net profit of Amerise Biosciences Ltd changed from ₹ -0.05 crore to ₹ -0.08 crore over 9 quarters. This represents a CAGR of 23.23% The net profit of Likhami Consulting Ltd changed from ₹ 0.02 crore to ₹ 0.01 crore over 9 quarters. This represents a CAGR of -26.51% The Dividend Payout of Amerise Biosciences Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Likhami Consulting Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Amerise Biosciences Ltd

Amerise Biosciences Limited was initially incorporated as 'Amstar Laminates Limited' in 1984 by a private Indian party, as a specialized manufacturer of high quality construction equipment and agricultural equipment.
On October 29, 2002, the name of the Company was changed from Amstar Laminates Limited to Amardeep Industries Limited and further to Amerise Biosciences Limited in August, 2021.
Initially, the Company was engaged into the business of commodity trading. During the financial year 2007 it entered into the trading of castor seeds.
During the year 2024-25, due to financial crisis Company has not carried out any business activities and faces huge set back.

About Likhami Consulting Ltd

Likhami Consulting Limited was formerly incorporated as Surana Construction Limited on April 20, 1982 and obtained the Certificate of Commencement of Business on 10th May 1982.
Subsequently, the name of the Company was changed from Surana Construction Limited to Spectrum Resources Limited and subsequently to Likhami Consulting Limited on 20 July, 2012 at Kolkata. The Company is engaged in the business of Consultancy, financial services and other allied services.
The Company operates mainly in Indian Market.
Management Consultancy, Project Consultancy, Consultancy to NGOs, Project Feasibility Studies, Techno-Economic Viability Studies, Market Survey, Research and Branding, Brand Launch Strategies, Industry Research, Project Report Preparation, Foreign Investments related consultancy in Indian Market, Financial Consultancy, Artificial Intelligent (AI), Technical Collaboration and International Tie-up, Turnaround Strategies for Distressed Firm Business Valuations, India Entry related consultancy, Financial Consultancy, Loan and Equity Syndication Services and Mergers & Acquisitions etc.

FAQs for the comparison of Amerise Biosciences Ltd and Likhami Consulting Ltd

Which company has a larger market capitalization, Amerise Biosciences Ltd or Likhami Consulting Ltd?

Market cap of Amerise Biosciences Ltd is 5 Cr while Market cap of Likhami Consulting Ltd is 307 Cr

What are the key factors driving the stock performance of Amerise Biosciences Ltd and Likhami Consulting Ltd?

The stock performance of Amerise Biosciences Ltd and Likhami Consulting Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Amerise Biosciences Ltd and Likhami Consulting Ltd?

As of October 25, 2026, the Amerise Biosciences Ltd stock price is INR ₹0.82. On the other hand, Likhami Consulting Ltd stock price is INR ₹309.0.

How do dividend payouts of Amerise Biosciences Ltd and Likhami Consulting Ltd compare?

To compare the dividend payouts of Amerise Biosciences Ltd and Likhami Consulting Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.